Clinical Trials Logo

Clinical Trial Summary

Asia has the highest burden with the largest contribution of pneumonia burden from India. Pneumonia is also observed as 5th leading cause of deaths in India. People with diabetes with uncontrolled glucose are significantly at higher risk of development of pneumonia. Even though, pneumonia is a vaccine-preventable disease, hospitalization for pneumonia of patients with diabetes are rising. Very limited literature is available on the knowledge and practice of pneumonia vaccination among diabetologists and the rate of pneumonia vaccination received by the patients with diabetes. Hence this study aims to assess their knowledge on the same. In addition, this study also aims to identify the real barriers and facilitators of pneumococcal vaccination among diabetologists in India. A cross-sectional study will be conducted among 25diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05721092
Study type Observational
Source M.V. Hospital for Diabetes
Contact
Status Completed
Phase
Start date February 20, 2023
Completion date March 22, 2024

See also
  Status Clinical Trial Phase
Completed NCT01521897 - Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan) N/A
Completed NCT03098628 - Trial of Simplified Pneumococcal Vaccination in Vietnam II Phase 2/Phase 3
Active, not recruiting NCT06337643 - A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine Phase 1
Recruiting NCT03046134 - Burden of Hospitalized Pneumonia in Korea COPD Population N/A
Completed NCT00689351 - Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea Phase 2
Recruiting NCT06181656 - Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Completed NCT05788510 - Pneumococcal Vaccination in Patients With Anti-TNF Alpha Therapy